Review Papers Claim by Claim

 Quick Explanation Copied

 Long Explanation

Core Findings & Mechanistic Map

The study screened 2,605 consecutive Enterobacteriaceae isolates from a single Shanghai hospital (Jan 2012–Jan 2013), identifying 26 tigecycline-nonsusceptible K. pneumoniae (TNSKP, 2.3%) Screening and MIC methodology. PCR sequencing found 23/26 (88.5%) carried ramR mutations and 10/26 (38.5%) carried acrR mutations—mostly novel at the time. qRT-PCR grouped isolates into distinct expression patterns: 8 with ramA/acrB/rarA/oqxB all upregulated, 8 with ramA/acrB only, 1 with rarA/oqxB/acrB only, 5 with ramA±oqxB but baseline acrB/rarA, and 4 with baseline expression of all four genes qRT-PCR expression patterns. Exclusion tests ruled out tetX orthologs, rpsJ mutations, and failed to reverse MICs with the efflux inhibitor PAβN, suggesting that 9 isolates had uncharacterized resistance pathways.

Notably, Proteus spp. and Providencia spp. showed high intrinsic-like non-susceptibility rates (59.1% and 45.7% respectively), consistent with known tigecycline resistance in these genera—not related to the K. pneumoniae mechanisms under study.

Regulatory Network & Comparison to Later Work

The mechanistic picture aligns with later confirmatory work: a 2017 Taiwanese study of 16 CRKP isolates found similar ramR mutations (A19V, L44R, L111R, E113K) plus novel tet(A) variants Taiwanese CRKP ramR/tet(A) study. A 2018 single-patient in vivo study provided direct evidence of rpsJ V57L evolution during tigecycline therapy In vivo rpsJ evolution during tigecycline therapy, and a 2017 Dalian study found that PAβN restored susceptibility in only some isolates—echoing the 'novel mechanisms' call from Sheng et al. Dalian non-tigecycline-treatment isolates study.

The 9 unexplained isolates (TNSKP18–26) are the study's most consequential observation—foreshadowing the later discovery of plasmid-mediated tmexCD1-toprJ1 RND pumps tmexCD1-toprJ1 plasmid transmission study and tet(A)-v variants tet(A)-v plasmid coexistence study that would not have been detected by the gene panel used here. The paper's key strengths are its systematic screening, use of triplicate MIC testing, and transparent acknowledgment of unexplained mechanisms; its key weaknesses are small TNSKP sample size (n=26), single-center scope, no whole-genome sequencing, no complementation/functional validation, and PAβN specificity issues (it primarily inhibits RND pumps but not all efflux classes). Confidence in the ramR/ramA pathway conclusions is moderate-high; confidence that the 9 unexplained isolates represent genuinely novel mechanisms is moderate given later discovery of plasmid-mediated pumps.

Best Evidence: TGC ResistanceMeta-analysis: ramR MutationsDesign WGS ExperimentsIdentify Drug Targets

Run AI Scientist Analysis

Author Review: Zi-Ke ShengAuthor Review: Fupin HuAuthor Review: Weixia WangAuthor Review: Qinglan GuoAuthor Review: Zhijun ChenAuthor Review: Xiaogang XuAuthor Review: Demei ZhuAuthor Review: Minggui Wang

 BGPT Paper Review

Study Novelty

At 2014 publication, the systematic survey of ramR/acrR mutations and RamA-driven efflux in 26 clinical TNSKP isolates was a meaningful extension of prior small-n studies; the observation of 9 unexplained isolates was prescient, anticipating later plasmid-mediated tmexCD1-toprJ1 and tet(A)-v discoveries.

Scientific Quality

Systematic broth microdilution with triplicate testing, transparent exclusion of alternative mechanisms (tetX, rpsJ, PAβN inhibitor), and clear reporting of negative/unexplained findings. Limitations: no WGS, no functional complementation, single-center, small TNSKP subset (n=26), and reliance on a single susceptible reference strain for expression fold-change normalization.

Study Generality

Findings on RamA/AcrAB/OqxAB pathways in K. pneumoniae have broad applicability across Enterobacteriaceae, though the 9 unexplained isolates limit the completeness of a unified resistance model.

Study Usefulness

Provides a mechanistic framework for molecular surveillance of tigecycline resistance in clinical K. pneumoniae and highlights that PCR-based panels miss unknown mechanisms—directly informing later WGS-based approaches.

Study Reproducibility

Primer sequences, qRT-PCR conditions, MIC methodology, and strain details are reported in sufficient detail for replication, but no raw Ct values or genome data were deposited.

Explanatory Depth

Links specific ramR/acrR mutations to downstream efflux gene overexpression and correlates expression levels with MIC values; however, causal proof via gene knockout/complementation is absent and 9/26 isolates remain mechanistically unexplained.